[go: up one dir, main page]

CL2019003232A1 - Vaccine compositions for infectious pancreatic necrosis virus (ipnv). - Google Patents

Vaccine compositions for infectious pancreatic necrosis virus (ipnv).

Info

Publication number
CL2019003232A1
CL2019003232A1 CL2019003232A CL2019003232A CL2019003232A1 CL 2019003232 A1 CL2019003232 A1 CL 2019003232A1 CL 2019003232 A CL2019003232 A CL 2019003232A CL 2019003232 A CL2019003232 A CL 2019003232A CL 2019003232 A1 CL2019003232 A1 CL 2019003232A1
Authority
CL
Chile
Prior art keywords
ipnv
vaccine compositions
pancreatic necrosis
necrosis virus
infectious pancreatic
Prior art date
Application number
CL2019003232A
Other languages
Spanish (es)
Inventor
Daral John Jackwood
Original Assignee
Ohio State Innovation Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/593,940 external-priority patent/US10086062B2/en
Application filed by Ohio State Innovation Foundation filed Critical Ohio State Innovation Foundation
Publication of CL2019003232A1 publication Critical patent/CL2019003232A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

COMPOSICIONES DE VACUNAS PARA VIRUS DE NECROSIS PANCREÁTICA INFECCIOSAS (IPNV)VACCINE COMPOSITIONS FOR INFECTIOUS PANCREATIC NECROSIS VIRUSES (IPNV)

CL2019003232A 2017-05-12 2019-11-11 Vaccine compositions for infectious pancreatic necrosis virus (ipnv). CL2019003232A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/593,940 US10086062B2 (en) 2012-07-05 2017-05-12 Infectious pancreatic necrosis virus (IPNV) vaccine compositions

Publications (1)

Publication Number Publication Date
CL2019003232A1 true CL2019003232A1 (en) 2021-01-22

Family

ID=64105474

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019003232A CL2019003232A1 (en) 2017-05-12 2019-11-11 Vaccine compositions for infectious pancreatic necrosis virus (ipnv).

Country Status (2)

Country Link
CL (1) CL2019003232A1 (en)
WO (1) WO2018209167A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008140610A2 (en) * 2006-12-20 2008-11-20 Advanced Bionutrition Corporation Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast
WO2014008475A2 (en) * 2012-07-05 2014-01-09 The Ohio State University Compositions and methods related to viral vaccines
US10086062B2 (en) * 2012-07-05 2018-10-02 Ohio State Innovation Foundation Infectious pancreatic necrosis virus (IPNV) vaccine compositions

Also Published As

Publication number Publication date
WO2018209167A1 (en) 2018-11-15

Similar Documents

Publication Publication Date Title
CL2017001798A1 (en) Pyrazine compounds for the treatment of infectious diseases.
PH12018501602A1 (en) Subunit immersion vaccines for fish
EA201691726A1 (en) NEW 6-CONDENSED HETEROARYDYDYDROPYRIMIDIDES FOR THE TREATMENT AND PREVENTION OF HEPATITIS B VIRUS INFECTION
IL289655A (en) Compounds useful for treating influenza virus infections
MX2017001862A (en) NEW PIRIDAZONAS AND TRIAZINONES FOR THE TREATMENT AND PROPHYLAXIS OF INFECTION BY VIRUSES OF HEPATITIS B.
CL2016000493A1 (en) Hcv polymerase inhibitors
CR20160241A (en) NEW DIHYDROCHINOLIZINONES FOR THE TREATMENT AND PROFILAXIS OF VIRUS INFECTION OF HEPATITIS B
EA201890493A1 (en) Htt repressors and their use
EA201791460A1 (en) N4-HYDROXYCYTIDINE AND RELATED DERIVATIVES AND OPTIONS FOR ANTI-VIRUS APPLICATION
EA201790630A1 (en) METHODS OF OBTAINING RIBOSIDS
EA201890736A1 (en) Modulators of the cow protein of the hepatitis B virus
MX2020012132A (en) AZAPIRIDONE COMPOUNDS AND USES THEREOF.
BR112018071048A2 (en) combinations and methods comprising a capsid assembly inhibitor
ZA202403393B (en) Synthetic chimeric poxviruses
MX2017011655A (en) AZA-PIRIDONA COMPOUNDS AND USES OF THESE.
PE20170440A1 (en) ISOINDOLINE DERIVATIVES
MX380393B (en) ATTENUATED INFLUENZA VECTORS FOR THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES AND FOR THE TREATMENT OF ONCOLOGICAL DISEASES.
DK3134094T3 (en) DEVICE FOR THE TREATMENT, TREATMENT OF COMPLICATIONS RESULTING FROM AND / OR PREVENTION OF AIR TRAFFIC DISEASES CAUSED BY INFECTIONS WITH BACTERIA, VIRUSES, PROTOSES, FUNGIES AND / OR ...
EP3870208A4 (en) IMMUNOGENIC ZIKA VIRUS COMPOSITIONS
CL2017000151A1 (en) Pyridone derivatives
EP3625349A4 (en) MODIFIED VIRUSES
BR112017027770A2 (en) compositions and methods for modulating viral infection
DK3615545T3 (en) PYRROLOPYRIMIDINE INTERVENTIVES USEFUL AS INHIBITORS OF REPLACEMENT OF INFLUENZA VIRUS
BR112016023833A2 (en) compounds, compositions, methods and use for treating or preventing hepatitis C virus infections
CO2020006181A2 (en) Environmentally friendly detergents for the inactivation of lipid-enveloped viruses